Emerging hepatic syndromes: pathophysiology, diagnosis and treatment

Intern Emerg Med. 2016 Oct;11(7):905-16. doi: 10.1007/s11739-016-1478-7. Epub 2016 Jun 7.

Abstract

Liver cirrhosis is a major cause of morbidity and mortality worldwide, mainly due to complications of portal hypertension. In this article, we review the current understanding on the pathophysiology, the diagnostic criteria and the available therapeutic options for patients with emerging hepatic syndromes in cirrhosis, namely the hepatorenal, hepato-adrenal and hepatopulmonary syndrome. The hepatorenal syndrome is a well-recognized complication of advanced cirrhosis and is usually associated with an accelerated course to death unless liver transplantation is performed. The hepatopulmonary syndrome is often missed in the evaluation of patients with cirrhosis; however, early recognition is essential for the efficient management of individual patients. The hepato-adrenal syndrome, although not fully characterized, offers an exciting field for research and potential therapeutic interventions.

Keywords: Cirrhosis; Hepato-adrenal; Hepatopulmonary; Hepatorenal.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / etiology
  • Adrenal Insufficiency / complications
  • Adrenal Insufficiency / etiology
  • Ascites / complications
  • Ascites / etiology
  • Creatinine / urine
  • Evidence-Based Medicine / methods
  • Hepatorenal Syndrome / complications*
  • Hepatorenal Syndrome / etiology
  • Hepatorenal Syndrome / physiopathology
  • Humans
  • Hypertension, Portal / complications*
  • Hypertension, Portal / physiopathology
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / physiopathology*
  • Liver Transplantation
  • Lypressin / analogs & derivatives
  • Lypressin / pharmacology
  • Lypressin / therapeutic use
  • Midodrine / pharmacology
  • Midodrine / therapeutic use
  • Norepinephrine / pharmacology
  • Norepinephrine / therapeutic use
  • Octreotide / pharmacology
  • Octreotide / therapeutic use
  • Plasma Substitutes / pharmacology
  • Plasma Substitutes / therapeutic use
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Serum Albumin / pharmacology
  • Serum Albumin / therapeutic use
  • Terlipressin
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use
  • Vasopressins / pharmacology
  • Vasopressins / therapeutic use

Substances

  • Plasma Substitutes
  • Serum Albumin
  • Vasodilator Agents
  • Vasopressins
  • Lypressin
  • Midodrine
  • Terlipressin
  • Creatinine
  • Octreotide
  • Norepinephrine